Defeating Antibiotic- and Phage-Resistant Enterococcus faecalis Using a Phage Cocktail in Vitro and in a Clot Model
Leron Khalifa1, Daniel Gelman1, Mor Shlezinger1,2
1Faculty of Dental Sciences, Hadassah School of Dental Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Abstract:
The deteriorating effectiveness of antibiotics is propelling researchers worldwide towards alternative techniques such as phage therapy: curing infectious diseases using viruses of bacteria called bacteriophages. In a previous paper, we isolated phage EFDG1, highly effective against both planktonic and biofilm cultures of one of the most challenging pathogenic species, the vancomycin-resistant Enterococcus (VRE). Thus, it is a promising phage to be used in phage therapy. Further experimentation revealed the emergence of a mutant resistant to EFDG1 phage: EFDG1r. This kind of spontaneous resistance to antibiotics would be disastrous occurrence, however for phage-therapy it is only a minor hindrance. We quickly and successfully isolated a new phage, EFLK1, which proved effective against both the resistant mutant EFDG1r and its parental VRE, Enterococcus faecalis V583. Furthermore, combining both phages in a cocktail produced an additive effect against E. faecalis V583 strains regardless of their antibiotic or phage-resistance profile. An analysis of the differences in genome sequence, genes, mutations, and tRNA content of both phages is presented. This work is a proof-of-concept of one of the most significant advantages of phage therapy, namely the ability to easily overcome emerging resistant bacteria.
Insights
Phage therapy offers a solution to antibiotic resistance. Researchers developed a phage cocktail effective against vancomycin-resistant Enterococci (VRE) and its resistant mutants, showcasing phage therapy
Area of Science:
- Microbiology and Virology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Antibiotic resistance is a growing global health threat.
- Phage therapy, using bacteriophages to treat bacterial infections, is a promising alternative.
- Vancomycin-resistant Enterococci (VRE) are a particularly challenging pathogen.
Purpose of the Study:
- To investigate phage therapy as a strategy against VRE.
- To address the challenge of phage-resistant bacterial mutants.
- To analyze phage characteristics for therapeutic applications.
Main Methods:
- Isolation and characterization of bacteriophage EFDG1 against VRE.
- Isolation and characterization of a new phage, EFLK1, effective against EFDG1-resistant VRE.
- Genomic analysis of both phages (EFDG1 and EFLK1).
- Evaluation of a phage cocktail comprising EFDG1 and EFLK1.
Main Results:
- Phage EFDG1 showed efficacy against planktonic and biofilm VRE.
- A resistant VRE mutant (EFDG1r) emerged, but was successfully targeted by a new phage, EFLK1.
- A phage cocktail of EFDG1 and EFLK1 demonstrated an additive effect against VRE, irrespective of resistance.
- Genomic comparison revealed differences in sequence, genes, mutations, and tRNA content between the two phages.
Conclusions:
- Phage therapy can overcome emerging bacterial resistance.
- A dual-phage cocktail strategy is effective against VRE and its resistant strains.
- Genomic analysis provides insights into phage-bacterial interactions and resistance mechanisms.
Related Concept Videos
Development of Antibiotic Resistance
Antibiotic Selection
Clot Retraction and Fibrinolysis
Resistivity
Resistance
Equivalent Resistance


